RGC
Roberts, Glore & Co’s Elevance Health ELV Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $1.09M | Buy |
2,809
+484
| +21% | +$188K | 0.32% | 79 |
|
|
2025
Q1 | $1.01M | Buy |
2,325
+113
| +5% | +$49.2K | 0.31% | 78 |
|
|
2024
Q4 | $816K | Buy |
2,212
+1,540
| +229% | +$568K | 0.24% | 90 |
|
|
2024
Q3 | $349K | Sell |
672
-11
| -2% | -$5.72K | 0.1% | 157 |
|
|
2024
Q2 | $370K | Hold |
683
| – | – | 0.11% | 146 |
|
|
2024
Q1 | $354K | Buy |
683
+144
| +27% | +$74.7K | 0.11% | 148 |
|
|
2023
Q4 | $254K | Sell |
539
-2
| -0.4% | -$943 | 0.08% | 179 |
|
|
2023
Q3 | $236K | Hold |
541
| – | – | 0.08% | 177 |
|
|
2023
Q2 | $240K | Buy |
541
+4
| +0.7% | +$1.78K | 0.08% | 180 |
|
|
2023
Q1 | $247K | Hold |
537
| – | – | 0.08% | 173 |
|
|
2022
Q4 | $275K | Sell |
537
-36
| -6% | -$18.5K | 0.1% | 151 |
|
|
2022
Q3 | $260K | Hold |
573
| – | – | 0.09% | 156 |
|
|
2022
Q2 | $277K | Hold |
573
| – | – | 0.09% | 154 |
|
|
2022
Q1 | $281K | Sell |
573
-2
| -0.3% | -$981 | 0.08% | 167 |
|
|
2021
Q4 | $267K | Hold |
575
| – | – | 0.07% | 168 |
|
|
2021
Q3 | $214K | Sell |
575
-20
| -3% | -$7.44K | 0.07% | 182 |
|
|
2021
Q2 | $227K | Hold |
595
| – | – | 0.07% | 179 |
|
|
2021
Q1 | $214K | Sell |
595
-102
| -15% | -$36.7K | 0.07% | 182 |
|
|
2020
Q4 | $223K | Buy |
+697
| New | +$223K | 0.07% | 170 |
|
|
2016
Q1 | – | Sell |
-1,468
| Closed | -$205K | – | 141 |
|
|
2015
Q4 | $205K | Sell |
1,468
-112
| -7% | -$15.6K | 0.16% | 130 |
|
|
2015
Q3 | $221K | Hold |
1,580
| – | – | 0.17% | 120 |
|
|
2015
Q2 | $259K | Sell |
1,580
-50
| -3% | -$8.2K | 0.18% | 116 |
|
|
2015
Q1 | $252K | Hold |
1,630
| – | – | 0.17% | 118 |
|
|
2014
Q4 | $205K | Buy |
+1,630
| New | +$205K | 0.14% | 134 |
|